Coronavirus disease (COVID-19) and disseminated intravascular coagulation syndrome
COVID-19 is an infectious disease caused by the beta-coronavirus SARS-CoV-2 that in 2020 has spread worldwide. In most severe patients, the clinical picture begins with respiratory failure further deteriorating up to multiple organ failure. Development of coagulopathy is the most adverse prognostic....
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IRBIS LLC
2020-07-01
|
| Series: | Акушерство, гинекология и репродукция |
| Subjects: | |
| Online Access: | https://www.gynecology.su/jour/article/view/633 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849697338167132160 |
|---|---|
| author | A. D. Makatsariya K. N. Grigoreva M. A. Mingalimov V. O. Bitsadze J. Kh. Khizroeva M. V. Tretyakova I. Elalamy A. S. Shkoda V. B. Nemirovskiy D. V. Blinov D. V. Mitryuk |
| author_facet | A. D. Makatsariya K. N. Grigoreva M. A. Mingalimov V. O. Bitsadze J. Kh. Khizroeva M. V. Tretyakova I. Elalamy A. S. Shkoda V. B. Nemirovskiy D. V. Blinov D. V. Mitryuk |
| author_sort | A. D. Makatsariya |
| collection | DOAJ |
| description | COVID-19 is an infectious disease caused by the beta-coronavirus SARS-CoV-2 that in 2020 has spread worldwide. In most severe patients, the clinical picture begins with respiratory failure further deteriorating up to multiple organ failure. Development of coagulopathy is the most adverse prognostic. Analyzing currently available clinical data revealed that 71.4 % and 0.6 % of survivors and fatal cases, respectively, demonstrated signs of overt disseminated intravascular coagulation (DIC). Monitoring D-dimer level, prothrombin time, platelet count and fibrinogen content is important for determining indications for treatment and hospitalization in COVID-19 patients. In case such parameters deteriorate, a more pro-active “aggressive” intensive care should be applied. Low molecular weight heparin (LMWH) should be administered to all patients with diagnosed COVID-19 infection (including non-critical patients) requiring hospitalization, but having no contraindications to LMWH. |
| format | Article |
| id | doaj-art-14918e6a22dc47bc8371a63352befc97 |
| institution | DOAJ |
| issn | 2313-7347 2500-3194 |
| language | Russian |
| publishDate | 2020-07-01 |
| publisher | IRBIS LLC |
| record_format | Article |
| series | Акушерство, гинекология и репродукция |
| spelling | doaj-art-14918e6a22dc47bc8371a63352befc972025-08-20T03:19:14ZrusIRBIS LLCАкушерство, гинекология и репродукция2313-73472500-31942020-07-0114212313110.17749/2313-7347.132544Coronavirus disease (COVID-19) and disseminated intravascular coagulation syndromeA. D. Makatsariya0K. N. Grigoreva1M. A. Mingalimov2V. O. Bitsadze3J. Kh. Khizroeva4M. V. Tretyakova5I. Elalamy6A. S. Shkoda7V. B. Nemirovskiy8D. V. Blinov9D. V. Mitryuk10Sechenov UniversitySechenov UniversitySechenov UniversitySechenov UniversitySechenov University«Medical Center» LLCSechenov University; Medicine Sorbonne University; Hospital TenonCity Clinical Hospital № 67 named after L.A. Vorokhobov, Moscow Healthcare Department;City Clinical Hospital № 67 named after L.A. Vorokhobov, Moscow Healthcare DepartmentInstitute for Preventive and Social Medicine; Lapino Clinic Hospital, MD Medical Group; Moscow Haass Medical – Social InstituteState Medical and Pharmaceutical University «Nicolae Testemitanu» Republic of MoldovaCOVID-19 is an infectious disease caused by the beta-coronavirus SARS-CoV-2 that in 2020 has spread worldwide. In most severe patients, the clinical picture begins with respiratory failure further deteriorating up to multiple organ failure. Development of coagulopathy is the most adverse prognostic. Analyzing currently available clinical data revealed that 71.4 % and 0.6 % of survivors and fatal cases, respectively, demonstrated signs of overt disseminated intravascular coagulation (DIC). Monitoring D-dimer level, prothrombin time, platelet count and fibrinogen content is important for determining indications for treatment and hospitalization in COVID-19 patients. In case such parameters deteriorate, a more pro-active “aggressive” intensive care should be applied. Low molecular weight heparin (LMWH) should be administered to all patients with diagnosed COVID-19 infection (including non-critical patients) requiring hospitalization, but having no contraindications to LMWH.https://www.gynecology.su/jour/article/view/633sars-cov-2covid-19coronavirusdisseminated intravascular coagulationdicanticoagulant therapylow molecular weight heparinlmwh |
| spellingShingle | A. D. Makatsariya K. N. Grigoreva M. A. Mingalimov V. O. Bitsadze J. Kh. Khizroeva M. V. Tretyakova I. Elalamy A. S. Shkoda V. B. Nemirovskiy D. V. Blinov D. V. Mitryuk Coronavirus disease (COVID-19) and disseminated intravascular coagulation syndrome Акушерство, гинекология и репродукция sars-cov-2 covid-19 coronavirus disseminated intravascular coagulation dic anticoagulant therapy low molecular weight heparin lmwh |
| title | Coronavirus disease (COVID-19) and disseminated intravascular coagulation syndrome |
| title_full | Coronavirus disease (COVID-19) and disseminated intravascular coagulation syndrome |
| title_fullStr | Coronavirus disease (COVID-19) and disseminated intravascular coagulation syndrome |
| title_full_unstemmed | Coronavirus disease (COVID-19) and disseminated intravascular coagulation syndrome |
| title_short | Coronavirus disease (COVID-19) and disseminated intravascular coagulation syndrome |
| title_sort | coronavirus disease covid 19 and disseminated intravascular coagulation syndrome |
| topic | sars-cov-2 covid-19 coronavirus disseminated intravascular coagulation dic anticoagulant therapy low molecular weight heparin lmwh |
| url | https://www.gynecology.su/jour/article/view/633 |
| work_keys_str_mv | AT admakatsariya coronavirusdiseasecovid19anddisseminatedintravascularcoagulationsyndrome AT kngrigoreva coronavirusdiseasecovid19anddisseminatedintravascularcoagulationsyndrome AT mamingalimov coronavirusdiseasecovid19anddisseminatedintravascularcoagulationsyndrome AT vobitsadze coronavirusdiseasecovid19anddisseminatedintravascularcoagulationsyndrome AT jkhkhizroeva coronavirusdiseasecovid19anddisseminatedintravascularcoagulationsyndrome AT mvtretyakova coronavirusdiseasecovid19anddisseminatedintravascularcoagulationsyndrome AT ielalamy coronavirusdiseasecovid19anddisseminatedintravascularcoagulationsyndrome AT asshkoda coronavirusdiseasecovid19anddisseminatedintravascularcoagulationsyndrome AT vbnemirovskiy coronavirusdiseasecovid19anddisseminatedintravascularcoagulationsyndrome AT dvblinov coronavirusdiseasecovid19anddisseminatedintravascularcoagulationsyndrome AT dvmitryuk coronavirusdiseasecovid19anddisseminatedintravascularcoagulationsyndrome |